General
AstraZeneca says coronavirus vaccine developed with Oxford can be up to 90 per cent effective
AstraZeneca says late-stage trials of its COVID-19 vaccine have been “highly effective” in preventing disease.
Researchers found that if people were given a half dose followed by a full dose of the vaccine, rather than two full doses, about 90 per cent of people were protected.
Where two full doses were given at least one month apart it showed 62 per cent efficacy.
The combined average across different…
Continue Reading
-
Noosa News23 hours agoAustralia Zoo reunites with the Ukrainian community
-
Noosa News23 hours ago“Hidden gem”: last chance for renovated bayside homes below $1m
-
Noosa News21 hours agoGame-changing Australian olive processing promises fruity flavour, lower farm costs
-
Business20 hours agoThe pros and cons of buying Accent shares after its decline